CA9 and breast cancer: In vitro studies revealed that AZB-I-CAIX2 was preferentially localized to the ER and selectively internalized in human breast cancer cells (MDA-MB-231) that overexpress CAIX (CAIX+), whereas AZB-I-control did not show any cell uptake.